These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2268692)

  • 1. Prostaglandin E2 levels in cerebrospinal fluid of normal and narcoleptic dogs.
    Nishino S; Mignot E; Kilduff TS; Sakai T; Hayaishi O; Dement WC
    Biol Psychiatry; 1990 Nov; 28(10):904-10. PubMed ID: 2268692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 and its methyl ester reduce cataplexy in canine narcolepsy.
    Nishino S; Mignot E; Fruhstorfer B; Dement WC; Hayaishi O
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2483-7. PubMed ID: 2928344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian variations of prostaglandins D2, E2, and F2 alpha in the cerebrospinal fluid of anesthetized rats.
    Pandey HP; Ram A; Matsumura H; Satoh S; Hayaishi O
    Biochem Biophys Res Commun; 1995 Aug; 213(2):625-9. PubMed ID: 7646520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of alpha 1-adrenoceptors blockade with prazosin in canine narcolepsy.
    Mignot E; Guilleminault C; Bowersox S; Rappaport A; Dement WC
    Brain Res; 1988 Mar; 444(1):184-8. PubMed ID: 2834022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF levels of prostaglandins, especially the level of prostaglandin D2, are correlated with increasing propensity towards sleep in rats.
    Ram A; Pandey HP; Matsumura H; Kasahara-Orita K; Nakajima T; Takahata R; Satoh S; Terao A; Hayaishi O
    Brain Res; 1997 Mar; 751(1):81-9. PubMed ID: 9098570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid prostaglandins and corticotropin releasing factor in schizophrenics and controls: relationship to sleep architecture.
    Nishino S; Mignot E; Benson KL; Zarcone VP
    Psychiatry Res; 1998 May; 78(3):141-50. PubMed ID: 9657418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of prostaglandins in the cerebrospinal fluid in cat, dog, and man.
    Romero SD; Chyatte D; Byer DE; Romero JC; Yaksh TL
    J Neurochem; 1984 Dec; 43(6):1642-9. PubMed ID: 6593432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers.
    John J; Wu MF; Maidment NT; Lam HA; Boehmer LN; Patton M; Siegel JM
    J Physiol; 2004 Oct; 560(Pt 2):587-92. PubMed ID: 15308685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems.
    Mignot E; Nishino S; Sharp LH; Arrigoni J; Siegel JM; Reid MS; Edgar DM; Ciaranello RD; Dement WC
    J Neurosci; 1993 Mar; 13(3):1057-64. PubMed ID: 8095066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic mechanisms in canine narcolepsy--II. Acetylcholine release in the pontine reticular formation is enhanced during cataplexy.
    Reid MS; Siegel JM; Dement WC; Mignot E
    Neuroscience; 1994 Apr; 59(3):523-30. PubMed ID: 8008206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeability of brain structures and other peripheral tissues to prostaglandins D2, E2 and F2 alpha in rats.
    Eguchi N; Kaneko T; Urade Y; Hayashi H; Hayaishi O
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1110-20. PubMed ID: 1527717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic mechanisms in canine narcolepsy--I. Modulation of cataplexy via local drug administration into the pontine reticular formation.
    Reid MS; Tafti M; Geary JN; Nishino S; Siegel JM; Dement WC; Mignot E
    Neuroscience; 1994 Apr; 59(3):511-22. PubMed ID: 8008205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological significance of prostaglandin E2 and D2 transport at the brain barriers.
    Tachikawa M; Hosoya K; Terasaki T
    Adv Pharmacol; 2014; 71():337-60. PubMed ID: 25307222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eicosanoid levels in CSF of premature infants with posthemorrhagic hydrocephalus.
    White RP; Leffler CW; Bada HS
    Am J Med Sci; 1990 Apr; 299(4):230-5. PubMed ID: 2321665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of cataplexy in genetically narcoleptic Dobermans.
    Riehl J; Nishino S; Cederberg R; Dement WC; Mignot E
    Exp Neurol; 1998 Aug; 152(2):292-302. PubMed ID: 9710528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of radioimmunoassays to measure prostaglandins F2 alpha and E2 in canine endometrium and plasma.
    Olson PN; Bowen RA; Behrendt MD; Olson JD; Nett TM
    Am J Vet Res; 1984 Jan; 45(1):119-24. PubMed ID: 6584054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocretin levels in sporadic and familial cases of canine narcolepsy.
    Ripley B; Fujiki N; Okura M; Mignot E; Nishino S
    Neurobiol Dis; 2001 Jun; 8(3):525-34. PubMed ID: 11442359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic studies in narcolepsy, a disorder affecting REM sleep.
    Faraco J; Lin X; Li R; Hinton L; Lin L; Mignot E
    J Hered; 1999; 90(1):129-32. PubMed ID: 9987919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity.
    Boehmer LN; Wu MF; John J; Siegel JM
    Exp Neurol; 2004 Aug; 188(2):292-9. PubMed ID: 15246829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The somnogenic T lymphocyte suppressor prostaglandin D2 is selectively elevated in cerebrospinal fluid of advanced sleeping sickness patients.
    Pentreath VW; Rees K; Owolabi OA; Philip KA; Doua F
    Trans R Soc Trop Med Hyg; 1990; 84(6):795-9. PubMed ID: 2096510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.